SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-002449
Filing Date
2023-01-23
Accepted
2023-01-23 17:40:39
Documents
2
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1484
2 EXHIBIT 24 brhc10046878_ex24.htm EX-24 9226
  Complete submission text file 0001140361-23-002449.txt   12020
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Cheung Lily (Reporting) CIK: 0001962207 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39303 | Film No.: 23545381